Beta Bionics, Inc. Balance Sheet
BBNX / Health Care|3 years of annual SEC 10-K data (FY2023-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 3 fiscal years. All figures from audited SEC 10-K filings.
Beta Bionics, Inc. had $329M in total assets and $288M in shareholders' equity as of FY2025.
Based on SEC 10-K filings.
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Cash & Equivalents | $31.6M | $30.4M | $26.6M |
| Accounts Receivable | $17.1M | $12.0M | $4.4M |
| Inventory | $21.7M | $13.3M | $1.2M |
| Current Assets | $267.9M | $132.9M | $103.6M |
| PP&E (Net) | $8.6M | $4.8M | $2.5M |
| Total Assets | $328.7M | $149.6M | $110.0M |
| Current Liabilities | $30.9M | $21.1M | $10.6M |
| Shareholders' Equity | $287.6M | -$245.4M | -$203.1M |